CD16-B Antibodies

Santa Cruz Biotechnology offers a broad range of CD16-B monoclonal antibodies for immunology and cell biology research. CD16-B monoclonal antibodies demonstrate high performance in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD16-B, also known as FcγRIII, plays a crucial role in the immune response by mediating antibody-dependent cellular cytotoxicity (ADCC) and enhancing phagocytosis. This receptor is primarily expressed on natural killer (NK) cells and certain macrophages, making it vital for the recognition and elimination of infected or malignant cells. Understanding the function of CD16-B is essential for developing therapeutic strategies in cancer and infectious diseases. CD16-B monoclonal antibodies enable precise detection and analysis of receptor expression patterns across different cell types. Researchers can utilize CD16-B monoclonal antibodies to investigate receptor-ligand interactions and signaling pathways. CD16-B monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing immune system research and developing new therapeutic approaches.